Skip to content

Design Therapeutics, Inc. DSGN Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

ALN
Alnylam PharmaceuticalsALNY
$6.32M-80.7%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$12.97M+6,050%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$247K-61.0%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$32.85M+757%
Vor Biopharma logo
Vor BiopharmaVOR
$6.36M+2,653%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$794K-24.5%

Other financials

Income statement

See full
Revenue-
Operating income-$19.7M+3.5%
Net income-$17.6M+0.4%
EPS (diluted)-$0.29+6.5%

Balance sheet

See full
Cash & equivalents$12.8M-6.6%
Total debt$2.7M+27.7%
Total equity$218.1M-4.3%
Total assets$230.4M-3.0%

Cash flow

See full
Operating cash flow-$16.4M+2.1%
CapEx--100%
Free cash flow-$16.4M+2.6%

Valuation

See full
Market cap$839.42M+295%
Enterprise value$829.39M+313%

Profitability

See full
Operating margin-3,685.8%
Net margin-3,663.7%

Returns & leverage

See full
Return on equity-31.3%+19.5pp
Debt / equity0.0×
Current ratio22.3×-6.1×

Where this comes from

Reported directly by Design Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Design Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Design Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
Design Therapeutics, Inc. (DSGN) reported increase (decrease) in prepaid expense and other assets of $287K in Q1 2026.
How has Design Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
Design Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets decreased by 79.6% year-over-year, from $1.41M to $287K.
What is the long-term trend for Design Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
Over 2 years (2021 to 2024), Design Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a -52.9% compound annual growth rate (CAGR), from $1.02M to -$226K.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.